Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02175316 · ClinicalTrials.gov registry record · NA
Enhanced External Counterpulsation on Delayed Onset Muscle Soreness
A NA study, sponsored by David Grant U.S. Air Force Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT02175316 is a NA study that has completed, run by David Grant U.S. Air Force Medical Center. The registered enrollment target is 18 participants.
The verdict
NCT02175316, a NA study, has completed, sponsored by David Grant U.S. Air Force Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
This study will evaluate the effects of Enhanced External Counterpulsation on delayed onset muscle soreness. The primary outcomes will be duration of delayed onset muscle soreness, WBC count, CRP count, CPK count, and pain tolerance.
Interventions
- DEVICE Enhanced External Counterpulsation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2014-04 |
| Est. Completion | 2017-09-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02175316
The ClinicalTrials.gov registry entry for NCT02175316 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is David Grant U.S. Air Force Medical Center, which has 21 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Enhanced External Counterpulsation is the first listed.
NCT02175316 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02175316 about?
NCT02175316 is a clinical study titled "Enhanced External Counterpulsation on Delayed Onset Muscle Soreness". This study will evaluate the effects of Enhanced External Counterpulsation on delayed onset muscle soreness. The primary outcomes will be duration of delayed onset muscle soreness, WBC count, CRP count, CPK count, and pain tolerance.
What is the current status of trial NCT02175316?
This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2014-04. Estimated completion is 2017-09-06.
What interventions are being tested in trial NCT02175316?
The interventions under investigation include: Enhanced External Counterpulsation (DEVICE).
Who is sponsoring clinical trial NCT02175316?
This trial is sponsored by David Grant U.S. Air Force Medical Center, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.